Acadia Healthcare

Acadia Healthcare

Price: 23.91

Company and Business Model

Acadia Healthcare operates in the healthcare sector, specializing in the provision of behavioral health services. The company primarily focuses on inpatient psychiatric care, residential treatment, and outpatient services. Its major business segments include acute care hospitals and outpatient facilities, with revenue generated mainly from patient services. Acadia Healthcare aims to address mental health issues through a range of treatment programs tailored to various patient needs.

Investment Profile

The investment profile of Acadia Healthcare suggests it may be more aligned with value investors, given its current financial metrics and market position. The stock exhibits characteristics that may appeal to those seeking stability rather than aggressive growth. The investment horizon could be medium-term, considering the company's operational challenges and market conditions. Liquidity is moderate, suitable for investors with basic experience in the healthcare sector.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
-12.24 Risk
Revenue QoQ — quarter-over-quarter revenue growth
0.9%
EPS surprise
32.1% better than expected
20d volatility
3.2% stable
FMP / FinFeed data updated: 2026-06-11
Reco: Sell Potential: 30 Risk: 75 Updated: 2026-06-11 05:29
How recommendation works
Why AI thinks so:
Weak fundamentals and negative momentum raise significant concerns.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-11 05:29 Hold Sell Weak fundamentals and negative momentum raise significant concerns.
2026-05-24 02:30 Sell Hold Weak fundamentals and negative momentum raise significant concerns.
2026-05-16 02:49 Hold Sell Weak fundamentals and high volatility raise concerns.
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-03 10:35 Jefferies Update — → 30 24.42
2026-05-27 11:06 KeyBanc Update — → 30 23.49
2026-05-04 13:25 RBC Capital Target Raised 28 → 31 29.75
Fluor Corporation Acadia Healthcare Victoria's Secret Verisign Centene

David Einhorn of Greenlight Capital Presents Five Turnaround Stock Picks at Sohn Investment Conference

David Einhorn, founder of Greenlight Capital, presented a bullish outlook on several underperforming companies at the Sohn Investment Conference, emphasizing that operational improvements and the adoption of artificial intelligence (AI) could lead to significant rebounds in their stock prices.
DHT Holdings SLM Corp Crocs Acadia Healthcare

Управляющий хедж-фондом Greenlight Дэвид Эйнхорн акцентирует внимание на защите капитала на фоне оптимизма на рынках

Управляющий хедж-фондом Greenlight Capital Дэвид Эйнхорн в своем последнем письме инвесторам выразил осторожность в условиях растущих рынков, связанных с оптимизмом по поводу геополитической ситуации.
Capri Holdings Graphic Packaging Global Payments Henry Schein Acadia Healthcare Centene

Инвестор Дэвид Эйнхорн избегает акций AI и увеличивает доли в Graphic Packaging (GPK) и Capri Holdings (CPRI)

Дэвид Эйнхорн, управляющий хедж-фондом Greenlight Capital, выразил свои опасения по поводу переоцененности акций на фондовом рынке, вызванной искусственным интеллектом.
Acadia Healthcare Unity Software

Акции Acadia Healthcare (ACHC) выросли на 10% после покупки акций инвестором Дэвидом Эйнгорном, в то время как акции Unity Software (U) упали на 30% из-за разочаровывающего прогноза выручки

На фондовом рынке произошли значительные изменения в ценах акций различных компаний.